OXT and obesity due to melanocortin 4 receptor deficiency: We found that 3V infusions of OT (1.6 and 16 nmol/day) produced dose-dependent reductions of weight gain and adiposity gain in HFD-fed rats in a diet-induced obesity prevention paradigm (N = 5–9/group).